Jan Musialkiewicz

Poznan, WP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Effective treatment of carcinoid syndrome with peptide receptor radionuclide therapy.

Effective treatment of carcinoid syndrome with peptide receptor radionuclide therapy.

Journal: Endokrynologia Polska

Published: June 12, 2026

Multidisciplinary management of severe refractory hypoglycemia.

Multidisciplinary management of severe refractory hypoglycemia.

Journal: Polish archives of internal medicine

Published: June 11, 2026

Carcinoid syndrome in neuroendocrine carcinoma mimicking Clostridioides difficile sepsis.

Carcinoid syndrome in neuroendocrine carcinoma mimicking Clostridioides difficile sepsis.

Journal: Endokrynologia Polska

Published: May 03, 2026

Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors.

Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors.

Journal: International journal of molecular sciences

Published: April 15, 2026

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

Journal: Nuclear medicine review. Central & Eastern Europe

Published: September 02, 2025

Multiple endocrinopathies presenting simultaneously with insulinoma as the leading manifestation.

Multiple endocrinopathies presenting simultaneously with insulinoma as the leading manifestation.

Journal: The American journal of medicine

Published: August 08, 2025

Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours.

Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours.

Journal: Endocrine connections

Published: June 13, 2025

Serum Visfatin/eNAMPT as a Biomarker in Pancreatic and Small Intestine Neuroendocrine Tumors: A Cross-Sectional Study and Future Perspectives.

Serum Visfatin/eNAMPT as a Biomarker in Pancreatic and Small Intestine Neuroendocrine Tumors: A Cross-Sectional Study and Future Perspectives.

Journal: Cancers

Published: June 12, 2025

Prevalence of Second Primary Malignancies in Patients With Well-Differentiated Neuroendocrine Tumors.

Prevalence of Second Primary Malignancies in Patients With Well-Differentiated Neuroendocrine Tumors.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: September 16, 2024

Hyperthyroidism caused by massive toxic nodular goiter accompanied by primary hyperparathyroidism.

Hyperthyroidism caused by massive toxic nodular goiter accompanied by primary hyperparathyroidism.

Journal: Polish archives of internal medicine

Published: July 15, 2024

Rapid-onset Cushing syndrome induced by adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor: a therapeutic challenge.

Rapid-onset Cushing syndrome induced by adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor: a therapeutic challenge.

Journal: Polish archives of internal medicine

Published: May 15, 2024

Serum β-hCG as a Biomarker in Pancreatic Neuroendocrine Tumors: Rethinking Single-Analyte Approach.

Serum β-hCG as a Biomarker in Pancreatic Neuroendocrine Tumors: Rethinking Single-Analyte Approach.

Journal: Cancers

Published: April 24, 2024

Showing 1-12 of 15

Last Updated: 09/26/2026